Coherus Oncology (CHRS)
Commercializes LOQTORZI while advancing mid-stage immuno-oncology antibodies.
$1.31
After hours+0.01 (+0.77%)
At close$1.30(−5.11%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 46.15% | 71.30M shares | |
|---|---|---|---|
| 152 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.95% | 1.47M shares | |
| 10 holders · as of Jun 9, 2026 | |||
| Other | ≈ 52.90% | 81.73M shares | |
| remainder | |||
154.50M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
152 holders · 71.30M shares · 13 new positions · 75 increased · 42 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust | 13.05M | 8.45% | +759.8K | Aug 7, 2026 |
| BlackRock, Inc. | 12.00M | 7.77% | +1.64M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 5.95M | 3.85% | +496.7K | Aug 13, 2026 |
| Geode Capital Management, LLC | 3.69M | 2.39% | +564.0K | Aug 12, 2026 |
| Samsara Biocapital, LLC | 3.43M | 2.22% | 0 | Aug 14, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 3.04M | 1.97% | 0 | Aug 14, 2026 |
| State Street Corp | 2.38M | 1.54% | +56.4K | Aug 7, 2026 |
| Two Sigma Investments, LP | 2.26M | 1.46% | −42.6K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Rubric Capital Management LPincl. David Rosen | 9.03% | 10.40M | 13G | Nov 13, 2024 |
| Timothy G. Youngquist 2020 Irrevocable Trust | 8.30% | 12.75M | 13G | May 15, 2026 |
| BlackRock, Inc. | 5.80% | 8.93M | 13G | Jul 27, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.